10:11 AM EDT, 10/16/2024 (MT Newswires) -- FibroBiologics ( FBLG ) said Wednesday it has received a new patent from the European Patent Office for a cancer treatment method that uses modified fibroblasts to deliver anti-cancer agents.

The patent covers methods to enhance fibroblasts' ability to target tumors and deliver cancer-fighting agents by leveraging their natural capacity to penetrate tumors and modulate immune responses, the clinical-stage biotechnology company said.

Shares of FibroBiologics ( FBLG ) were up more than 14% in recent trading.

Price: 3.11, Change: +0.36, Percent Change: +13.09